Cal-Maine Foods facility hit by avian flu, 1.4m hens affected

Cal-Maine Foods (CALM) reported avian flu at a Florida facility, affecting 1.4 million hens (2.7% of total flock). Production halted temporarily. The company plans to maintain supply continuity and will update in its next quarterly report. The USDA and CDC note low human risk, and no egg recalls are in effect.

Original reporting
Published Nov 18, 2026, 2:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 18, 2026, 2:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CALM
Bearish
medium confidence
Mentioned
$CALM
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CALMBearishMed
01

Why it matters

The immediate tradable angle is operational disruption at a specific facility (production temporarily ceased) plus quantified flock impact, with management signaling supply continuity via diversified production and no interim updates unless material.

02

Market read

A quantified avian flu event at Cal-Maine’s facility creates near-term supply and sentiment risk, even as the company frames the impact as a small share of total flock and notes no egg recalls.

03

What to watch

Markets may overreact to the facility halt without waiting for how quickly restocking and distribution ramp occurs, and without considering that no eggs are recalled and human health risk is assessed as low.

Relevance 7/10Novelty 7/10Timing: today’s disclosure of facility depopulation and temporary production halt

Background

Highly pathogenic avian influenza outbreaks can force depopulation and temporary production stoppages; Cal-Maine notes prior impacts in fiscal 2024 Q3-Q4 and again in March 2026.

Company-level read

Ticker impact

$CALMBearishMedium confidence
Context

Cal-Maine Foods says a Florida facility tested positive for highly pathogenic avian influenza, triggering depopulation of about 1.4M hens and halting production there.

Expected impact

Likely downside bias as markets price temporary supply loss and ongoing outbreak risk, partially offset by the company’s diversified network and no egg recalls.

Evidence & confidence

The article discloses a specific outbreak at a named facility with quantified bird losses and a temporary production cease, which can pressure near-term supply and sentiment. However, it also states only 2.7% of total flock was affected and no eggs are recalled, limiting worst-case impact.

Market effects

Highlights ongoing avian influenza risk for egg producers, potentially supporting broader egg pricing expectations while increasing volatility around supply disruptions.

Florida facility disruption may tighten local supply, though the company’s multi-location network is intended to smooth regional shortages.

Primarily US-focused; could marginally affect global protein sentiment if outbreaks broaden, but the article emphasizes low human risk and no recalls.

Counterpoint

Because the affected birds are only 2.7% of the total flock and the company is coordinating production across locations, the financial impact may be limited versus typical outbreak fears.

Key entities

  • Cal-Maine Foods, Inc.

    Largest US egg company; reported a Florida facility tested positive for highly pathogenic avian influenza, leading to depopulation of ~1.4M hens and ~360k pullets.

  • U.S. Department of Agriculture (USDA)

    Prescribed protocols Cal-Maine is following after the facility tested positive.

  • U.S. Centers for Disease Control and Prevention (CDC)

    Assessed human health risk from highly pathogenic avian influenza viruses as low for the general US public.

Related articles

$CALMMed

Cal-Maine to cull 1.8 million birds, halt production at Florida facility after bird flu detected

Cal-Maine Foods will cull 1.8 million birds and halt production at a Florida facility after detecting avian influenza. The cull includes 1.4 million laying hens and 360,000 pullets, representing 2.7% of its flock. The company is following USDA protocols. Bird flu has disrupted food supplies and driven up prices, though human infection risk is low, according to the CDC.

$CALMMed

Maybe There Was an Egg Cartel After All

Egg prices in the U.S. surged in 2022, initially attributed to bird flu. However, federal investigators allege that Cal-Maine, Hickman's, and Versova coordinated to artificially inflate prices through surplus bids. Prices rose 120% by December. Cal-Maine, a publicly traded company, cited the flu in its investor announcement. Antimonopoly group Farm Action questioned the price hikes, noting flock sizes didn't justify the increase.

$CALMMed

Cal-Maine Foods (CALM), Why Is It Back In Focus Today?

Cal-Maine Foods (CALM) reported a first-quarter net loss of $58.62M, down from a profit a year ago, with sales at $539.61M. The stock has declined 10.67% over 30 days and 21.94% over 90 days, but remains up 64.84% and 149.34% over three and five years. The company is expanding specialty egg and prepared foods offerings, aiming for higher margins. Analysts estimate a fair value of $68.33, with the stock currently trading at $66.67. Risks include avian influenza and oversupply pressures.

$CALMMedAI 8/10

Is Cal-Maine’s (CALM) Egg Slump Already Priced Into the Stock?

Cal-Maine Foods (CALM), the largest US egg producer, reported a weak Q1 FY2027 with net sales down 41.5% to $539.6M and a net loss of $58.6M. Specialty eggs and prepared foods, now 54.1% of sales, remained profitable. Retail demand for specialty eggs and exports rose, while supply may be tightening. Management is expanding prepared foods capacity. Conventional eggs, still dominant, saw a 59.5% sales drop due to price declines.